Education
About Us
Working with TipRanks
Follow Us
Joseph McCracken Insider Profile
4 Followers
Joseph McCracken, Director at Nexvet Biopharma, holds 260.84K shares in Savara (Ticker: SVRA), holds 0.00 shares in Lumos Pharma (Ticker: LUMO), holds 6.20K shares in Nexvet Biopharma (Ticker: NVET). Most recently, Joseph McCracken Bought ― shares of Savara on Jun 02, 2025 for an estimated value of 20.80K.
Profitable Transactions
3 out of 7 Profitable Transactions
Average Return
-1.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Joseph McCracken's holdings
Insider Roles
Director
Roles that Joseph McCracken holds in companies
Most Profitable Insider Trade
The most profitable trade made by Joseph McCracken
Joseph McCracken's Trading History
Nexvet Biopharma
Aug 02, 2017
―
Uninformative Sell
110.21K
$41.66K
Savara
Jun 02, 2025
Director
Informative Buy
20.80K
$675.57K
Kindred Biosciences
―
―
―
―
Lumos Pharma
Dec 13, 2024
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Joseph McCracken's performance on stock
You May Also Like
Joseph McCracken insider profile FAQ
What is the percentage of profitable transactions made by Joseph McCracken?
The percentage of profitable transactions made by Joseph McCracken is 43%.
What is the average return per transaction made by Joseph McCracken?
The average return per transaction made by Joseph McCracken is -1.00%.
What stocks does Joseph McCracken hold?
Joseph McCracken holds: NVET, SVRA, KIN, LUMO stocks.
What was Joseph McCracken’s latest transaction?
Joseph McCracken latest transaction was an Informative Buy of $20.80K.
What was Joseph McCracken's most profitable transaction?
Joseph McCracken’s most profitable transaction was an Informative Buy of SVRA stock on June 9, 2017. The return on the trade was 85.20%.
What is Joseph McCracken's role in Nexvet Biopharma?
Joseph McCracken's role in Nexvet Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.